Filters
Term Search
You can select from the dropdown list OR enter your own terms to refine the search.
Last Updated: 10/31/2025
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 2868 publications
In vitro evolution of durlobactam resistance in NDM-producing Escherichia coli due to a single mutation in mrdA encoding penicillin-binding protein 2.
Journal: Antimicrobial agents and chemotherapy
Published: October 10, 2025
Severe delayed coagulopathy caused by cefoperazone/sulbactam: A case report.
Journal: The Journal of international medical research
Published: October 01, 2025
Pharmacokinetic drug evaluation of co-packaged sulbactam for injection and durlobactam for injection for the treatment of Acinetobacter baumannii-calcoaceticus complex in HABP/VABP.
Journal: Expert opinion on drug metabolism & toxicology
Published: September 26, 2025
Pharmacokinetics of sulbactam-durlobactam in patients with Acinetobacter baumannii ventriculitis: a report of two cases.
Journal: Antimicrobial agents and chemotherapy
Published: September 22, 2025
Predictive Analysis of Coagulation Dysfunction in Elderly Patients Caused by Cefoperazone Sodium-Sulbactam Sodium Use.
Journal: Annals of clinical and laboratory science
Published: September 17, 2025
New Perspectives on Antimicrobial Agents: Sulbactam-durlobactam.
Journal: Antimicrobial agents and chemotherapy
Published: August 22, 2025
Structural insights into the activity of carbapenemases: understanding the mechanism of action of current inhibitors and informing the design of new carbapenem adjuvants.
Journal: RSC medicinal chemistry
Published: August 21, 2025
Combinations comprising dual β-lactams and a β-lactamase inhibitor achieve optimal synergistic inhibition of Mycobacterium abscessus growth.
Journal: Antimicrobial agents and chemotherapy
Published: August 14, 2025
In vitro activity of sulbactam in combination with other antimicrobial agents against extensively drug-resistant Acinetobacter baumannii.
Journal: Microbiology spectrum
Published: August 12, 2025
It is time to go beyond the association between colistin and meropenem for invasive carbapenem-resistant Acinetobacter baumannii infections.
Journal: Clinical infectious diseases : an official publication of the Infectious Diseases Society of America
Published: August 11, 2025
Adverse Event Signals Associated with Beta-Lactamase Inhibitors: Disproportionality Analysis of USFDA Adverse Event Reporting System.
Journal: Journal of xenobiotics
Published: August 07, 2025
Last Updated: 10/31/2025